HAO Valuation

Haoxi Health Technology Ltd

Add to Watchlist

Advanced Chart

1.350

-0.03(-2.174%)1D

Overview
Forecast
Valuation
Earnings

HAO Relative Valuation

HAO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HAO is overvalued; if below, it's undervalued.

Historical Valuation

Haoxi Health Technology Ltd (HAO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Haoxi Health Technology Ltd (HAO) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.38

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.21

P/B

Median3y

43.50

Median5y

43.50

-84.61

FCF Yield

Median3y

-21.42

Median5y

-21.42

Competitors Valuation Multiple

The average P/S ratio for HAO's competitors is 0.17, providing a benchmark for relative valuation. Haoxi Health Technology Ltd Corp (HAO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HAO.O

Haoxi Health Technology Ltd

Loss

Average P/S: 0.17

3.81M